MATEON THERAPEUTICS INC Uncategorized Contracts & Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Term Sheet Between Mosaic ImmunoEngineering, Inc. and Oncotelic Therapeutics, Inc. Extending Expiration Date
Modification Agreements
MATEON THERAPEUTICS INC
Biotechnology
2025
Exclusive License Agreement between Oncotelic Inc. and Autotelic Bio for Trabedersen (OT-101) Combination Therapy
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2020
Placement Agent Engagement Letter between Mateon Therapeutics, Inc. and Divine Capital Markets LLC (February 7, 2018)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2018
Mateon Therapeutics, Inc. Common Stock Certificate (Specimen)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
2016
Amendment No. 9 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2015
Amendment No. 8 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2014
Amendment No. 7 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Modification Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2013
Amended and Restated Placement Agent Agreement between OXiGENE, Inc. and H.C. Wainwright & Co., LLC
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Amendment No. 6 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2013
Registration Rights Agreement between OXiGENE, Inc. and Lincoln Park Capital Fund, LLC (November 28, 2011)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2011
Amendment No. 5 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2011
Amendment No. 4 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2011
At Market Issuance Sales Agreement between OXiGENE, Inc. and McNicoll, Lewis & Vlak LLC (July 21, 2010)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Amendment No. 3 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2010
Placement Agent Agreement between OXiGENE, Inc. and Lazard Capital Markets LLC and Merriman Curhan Ford & Co. dated July 15, 2009
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2009
Amendment No. 1 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company (March 24, 2005)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2005
Placement Agency Agreement between OXiGENE, Inc. and Lehman Brothers, Rodman & Renshaw, and Roth Capital Partners (January 13, 2004)
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2004
Finders Fee Agreement between Oncotelic Therapeutics, Inc. and JH Darbie & Co., Inc., dated October 26, 202
MATEON THERAPEUTICS INC
Biotechnology
2021
Data Processing Agreement between Mateon Therapeutics Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Addendum #1 to Expanded Access Program Master Services Agreement between Mateon Therapeutics, Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Statement of Work #1 under Expanded Access Program Master Services Agreement between Mateon Therapeutics, Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Expanded Access Program Master Services Agreement between Mateon Therapeutics Inc. and Impatients N.V.
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Contingent Value Rights Agreement among Mateon Therapeutics, Inc., Oncotelic, Inc., and Others, dated April 17, 2019
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Consulting Services Exhibit B to Consulting Agreement between OXiGENE, Inc. and David Chaplin, Ph.D.
Consulting Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2011